XELRYX-3

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameXELRYX-3
Drug Alias Namexenomycins (Panacela Labs)PLX01008-00-01PLX-1008XEN-FXEN-M +[6] 
ClassificationSmall molecules
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsMalariaParasitic DiseasesMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPanacela Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPanacela Labs Inc
Active IndicationsN/A
Inactive IndicationsMalariaParasitic DiseasesMycoses

Other Information

ATC CodeN/A
Related LinksN/A